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This study aimed to describe HIV testing uptake, as well as HIV prevalence and its associ-
ated factors among older adults aged�50 years in health facilities in Togo.
Methods
A cross-sectional study was carried out from February 2018 to June 2019 among hospital-
ized older adults aged�50 years in tertiary and secondary hospitals in Togo. HIV testing
was performed according to the national algorithm. Socio-demographic data and HIV testing
history were collected using a standardized questionnaire.
Results
A total of 619 patients (43.9% female) of median age 61 years, (IQR: 55–70) were recruited
and offered HIV testing. Among them, 25.7% had never previously tested for HIV. In total,
91.6% (567/619) accepted HIV testing while 8.4% (52/619) refused to be tested. Of those
who tested, forty patients were HIV positive, yielding a prevalence of 7.1%. Twenty-three
patients (57.5%) were newly diagnosed with HIV infection. In multivariable analysis, two fac-
tors were associated with HIV infection: living alone (aOR = 5.83; 95%CI = [2.26–14.53])
and being <60 years (aOR = 3.12; 95%CI = [1.51–6.66]).
Conclusion
The majority of older adults in this study accepted testing for HIV and almost three in five
HIV positive older adults were newly diagnosed with HIV as a result of this testing. There is
an urgent need to integrate older adults into responses to the HIV epidemic and to
strengthen targeted prevention care and treatment in this population.
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Introduction
According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), the number of
people living with HIV aged 50 and older (PLWH50+) has increased in all regions of the world
[1]. Between 2000 and 2019, the number of PLWH50+ has more than doubled in West and
Central Africa, while it has quadrupled in Eastern and Southern Africa; in Western and Cen-
tral Europe and North America, it showed a ten-fold increase [2]. Globally, the proportion of
PLWH50+ increased from 8% of all people living with HIV in 2000 to almost 21% in 2019 [2].
In 2019, there were 7.9 million PLWH50+ worldwide [2].
Large-scale access to antiretroviral therapy (ART) has greatly contributed to the increase in
the number of older people living with HIV (PLWH). Early initiation of ART has led to a
decline in AIDS-related deaths by 43% since 2003 and nowadays, PLWH who start ART could
expect to live as long as an HIV-negative person of the same age [3, 4]. Besides large-scale
access to ART, the ageing of the population in all regions of the world has led to new infections
being reported among older adults. In the United States (US), around one in six new HIV
diagnoses occurred among people aged�50 years in 2017 [5], while an analysis of surveillance
data from 31 European countries reported a significant increase in the notification rate of new
diagnoses among older adults between 2004–2015 [6].
The ‘greying of the HIV epidemic’ raises important public health issues including low rates of
HIV testing which have been reported among older adults. In a study conducted among 12,366
people aged�50 years in the US, only 25.4% reported lifetime testing for HIV, and of those who
had been tested, 69.7% reported having tested more than five years prior to survey [7]. With
regards to new infections, older adults are more likely to be diagnosed at a late stage in the course
of the HIV disease than younger people [6, 8]. Late diagnosis among older adults is of great con-
cern as it is associated with adverse outcomes such as rapid progression to AIDS, presence of age-
ing-related comorbidities and high mortality rate [9–11]. To improve early detection of HIV
infection, especially among populations otherwise unlikely to obtain an HIV test like older adults,
implementation of routine HIV testing is the best strategy and it is recommended for everyone
between the ages of 13 and 64 in the US [9, 12]. However, less than two older adults in five in the
US who tested for HIV were offered HIV testing during routine medical check-up [7].
In Sub-Saharan Africa (SSA) which bears the heaviest burden of the HIV epidemic, evi-
dence on older PLWH is beginning to emerge [13–20]. Estimates of HIV prevalence among
older adults aged�50 years have been reported in Tanzania where it ranged from 1.7% [17] to
6.7% [18, 19], in Botswana (the rate was 21.9% in females and 27.8% in males [15]), whilst in
South Africa, it was 20% [20]. HIV testing among older adults remains a challenging issue in
SSA. Although various HIV testing strategies such as voluntary counselling and testing (VCT),
provider-initiated testing and counselling (PITC), diagnostic testing and counselling, home-
based counselling and testing, and self-testing are available in SSA countries, HIV testing pro-
grams do not specifically target older adults [16, 21, 22]. Also, studies have uncovered that
older PLWH in SSA are often unaware of treatment options and availability and they have
inadequate access to health services [15]. However, most of these studies were conducted in
Eastern and Southern Africa and do not report new HIV infections. In Togo, as in most SSA
countries, national adult population surveys on HIV are generally limited to the 15–49 age
group and in 2018, the prevalence of HIV was 2.3% [23]. According to the UNAIDS, it was
estimated that among the 120,000 PLWH in Togo in 2019, 20,000 (16.7%) were aged�50
years [2]. To our knowledge, only one study has focused on the burden of the HIV epidemic
among older adults in Togo and reported extrapolated prevalence based on existing data in
2010 [24]. The present study aimed to describe uptake of HIV testing, as well as HIV preva-
lence and its associated factors among older adults aged�50 years in health facilities in Togo.
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Methods
Study design and settings
This cross-sectional study was conducted in Togo, a country of West Africa which covers an
area of 56,800 Km2 with an average density of 145 inhabitants per square kilometer. The popu-
lation was 7.89 million in 2018, of which 50.2% are women. Most of the population is young
(60% of Togolese are under 25 years of age), and lives in rural areas (62%). Togo health system
has a three-level pyramid structure: central, intermediate and peripheral levels. For each level,
there are administrative and healthcare delivery components. Regarding health care for older
adults, no geriatric wards are available in the country.
This study was part of the Study of Hospitalized Older adults in Togo (SHOT) which aimed
to describe comorbidities and mortality after hospitalization among older adults aged�50
years in Togo [25]. The SHOT project was carried out in two steps: face-to-face interview at
baseline during hospitalization and telephone interviews at one (M1), three months (M3), six
months (M6), and twelve months (M12) after hospital discharge. Baseline interviews were con-
ducted from February 2018 to June 2019 in the medicine and surgery hospitalization wards of
the three main tertiary level hospitals and secondary level hospitals according to the health pyr-
amid in Togo. Results of HIV testing which was offered at baseline during hospitalization are
reported in the present cross-sectional study.
Study population and sample size
Patients aged�50 years who were hospitalized in adult medical and surgical wards of partici-
pating hospitals during the study period were eligible to participate in the study. Exclusion cri-
teria were inability to provide consent for HIV testing due to altered mental status or critical
medical condition.
Since no data on HIV testing uptake among older adults were available in Togo, the sample
size calculation was based on an expected HIV testing uptake in older adults aged�50 years of
73% based on the estimate reported in health facilities in SSA [26], with a precision of 4%, a
significance level set at 5%, and a non-response rate of 10%; the minimum sample size was esti-
mated at 522 patients. This sample size was also adequate for the estimation of HIV prevalence
among older adults based on the following assumptions: an expected HIV prevalence in older
adults aged�50 years of 2.3% based on the estimate reported in the general population (15–49
years) in Togo [23], with a precision of 2%, a significance level set at 5%, and a non-response
rate of 10%, yielding a minimum sample size of 237 patients.
Data collection
Prior to the study, the ten final-year medical students who enrolled the patients received train-
ing on HIV testing issues (counselling, obtaining consent, delivering post-test results in coor-
dination with on-site HIV management staff) and on the interview questionnaire. All eligible
patients were informed of the study procedures and were invited to participate. After informed
consent, sociodemographic data and information regarding HIV testing history, and knowl-
edge of their principal sexual partner’s HIV status were recorded. For participants who
reported being HIV positive or being tested during their stay at the hospital, medical records
were assessed to collect information on their HIV testing history and status.
HIV testing
HIV testing was performed according to the national algorithm in Togo, where HIV testing
strategies are based on VCT and PICT. PICT is proposed to pregnant women, children aged
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18–59 months, key populations and to all other adults. For the present study, HIV testing was
proposed to all patients with and without history of HIV testing. Study participants who
refused to be surveyed were asked to provide the reasons for their refusal.
A small amount of blood was collected by finger prick to perform rapid point-of-care HIV
testing using Alere DetermineTM HIV1/2 Ag/Ab Combo (Alere Medical Co. Ltd., Chiba,
Japan). Each HIV positive test was confirmed with another HIV rapid test, the First
Response1HIV 1-2-O Card Test (Premier Medical Corporation Pvt. Ltd., Maharashtra,
India). In case of discordant results, venous blood samples were drawn and tested with the
INNO-LIA1HIV I/II Score (20T) (Fujirebio, Göteborg, Sweden) line immunoassay at the
main HIV laboratory research unit, the Molecular Biology Laboratory (BIOLIM) at the Uni-
versity of Lomé.
Counselling and risk prevention interventions were provided to patients who were tested
negative for HIV. Positive results were disclosed by a senior medical officer in charge in the
service where newly HIV positive patients were diagnosed. Senior medical officers also empha-
sized the benefits of medical care and treatment before referring newly diagnosed HIV patients
to the HIV care center.
Statistical analysis
Descriptive statistics were performed and results were presented with frequency tabulations
and percentages for categorical variables. Quantitative variables were presented as medians
with their interquartile range (IQR). HIV prevalence was estimated with corresponding 95%
confidence interval (95%CI) based on estimation of confidence interval for a proportion [27].
Comparisons of medians were performed using Mood’s Median test as it is more resistant to
outliers and is more appropriate when distributions in the sub-populations being compared
differ (one symmetrical and the other asymmetrical). Proportions were compared using Chi-
squared test when sample size of all cells was greater than 5 or Fisher’s exact test when at least
one cell was below 5 [28]. Binary logistic regression analyses were performed to identify factors
associated with HIV infection among older adults. In the univariable logistic regression, vari-
ables with a p-value < 0.20 were fitted into the multivariable analyses. A backward procedure
approach was performed for selection of variables and adjusted odds ratio (aOR) were
reported with their 95% CI. All analyses were performed using R1 software. The significance
level was set at 5%.
Ethical considerations
All eligible patients received detailed information about the study purpose and procedures,
voluntary participation, HIV testing, potential risks and protections. Recruited patients pro-
vided written signed informed consent prior to the administration of the questionnaire and
additional consent was obtained prior to HIV testing. This study was approved by the “Comité
de Bioéthique pour la Recherche en Santé (CBRS)” (Bioethics Committee for Health Research)
from the Togo Ministry of Health (n˚09/2018/CBRS).
Results
A total of 659 eligible older adults were recruited for the purpose of the SHOT project during
the study period. Forty older adults were unable to provide consent for HIV testing because of
their general health status (coma, stroke) and a total of 619 adults were offered HIV testing
and included in the final analysis.
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Socio-demographic characteristics
The median age of the 619 participants was 61 years, (IQR: 55–70) (Table 1). Women repre-
sented 43.9% of the sample and they were more likely to be widowed (p<0.001) and have no
formal or primary level education (p<0.001). Almost three quarters (73.8%) of the study popu-
lation did not have health insurance. Men were more likely to have health insurance
(p<0.001) and have higher monthly income (p<0.001) compared with women.
Table 1. Socio-demographic characteristics of hospitalized older adults in Togo in 2018–2019 (N = 619).
Total (N = 619) Male (N = 347) Female (N = 272) P-value
N % N % N %
Age (years), median (IQR) 61 (55–70) 60 (55–68) 62 (57–70) 0.002�
Age (years) 0.021��
50–59 262 42.3 161 46.4 101 37.1
� 60 357 57.7 186 53.6 171 62.9
City of residence 0.513��
Lomé 359 58.0 204 58.8 155 57.0
Other cities 182 29.4 104 30.0 78 28.7
MD 78 12.6 36 11.2 39 14.3
Marital status <0.001���
Married/Living with a partner 403 65.1 304 87.6 99 36.4
Widow 170 27.5 27 7.8 143 52.6
Living alone 43 6.9 14 4.0 29 10.7
MD 3 0.5 2 0.6 1 0.3
Education level <0.001��
No formal education 173 27.9 48 13.8 125 46.0
Primary school 158 25.5 88 25.4 70 25.7
Secondary/ University 275 44.4 204 58.8 71 26.1
MD 13 2.2 7 2.0 6 2.2
Main source of monthly revenue <0.001��
None 31 5.0 11 3.2 20 7.4
cFinancial aid 184 29.7 71 20.5 113 41.5
Pension fund 103 16.6 83 23.9 20 7.4
Income generating activity 278 45.0 169 48.7 109 40.1
MD 23 3.7 13 3.7 10 3.6
Monthly income (Euros) <0.001��
< 53 136 22.0 58 16.7 78 28.7
53–152 329 53.2 189 54.5 140 51.5
� 153 118 19.1 84 24.2 34 12.5
MD 36 5.7 16 4.6 20 7.3
Health insurance <0.001���
Yes 157 25.4 120 34.6 37 13.6
No 457 73.8 225 64.8 232 85.3
MD 5 0.8 2 0.6 3 1.1
�Mood’s median test
��Chi-square test
���Fisher’s exact test; IQR: Interquartile range; MD: missing data.
https://doi.org/10.1371/journal.pone.0246151.t001
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History of HIV testing and uptake
Among the 619 older adults who were included in the study, 159 (25.7%) had never been tested
for HIV and only 271 (43.7%) were tested during hospitalization, prior to our survey. In total,
91.6% (567/619) accepted HIV testing while 8.4% (52/619) refused to be tested; there was a sta-
tistical difference of HIV refusal proportions (p = 0.018) according to HIV history. Main rea-
sons for HIV test refusal were ‘I do not want to be tested again’, ‘I am not at risk’, or there was
no specific reason. History of HIV testing and uptake are summarized in Fig 1.
HIV prevalence
Forty hospitalized older adults (of 567 tested) were positive for HIV, yielding a prevalence of
7.1%, 95%CI: [5.1–9.5]. Among HIV seropositive older adults, 23 (57.5%) were newly diag-
nosed as a result of this testing.
HIV prevalence was higher among older adults who were living alone (22.2%) compared
with those who were widowed (5.7%) or married/living with a partner (5.9%) (p<0.001). Also,
HIV prevalence was higher in those aged 50–59 years compared with their older counterparts
(11.0% and 4.2%; p = 0.002). There was no statistical difference according to sex (6.9% in
males, 7.2% in females; p = 0.954).
Fig 1. HIV testing history and uptake among hospitalized older adults in Togo in 2018–2019.
https://doi.org/10.1371/journal.pone.0246151.g001
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In multivariable analysis, two factors were associated with HIV infection: marital status (liv-
ing alone) (aOR = 5.83; 95%CI = [2.26–14.53]) and being <60 years of age (aOR = 3.12; 95%
CI = [1.51–6.66]). These results are presented in the Table 2.
Discussion
The present study explored uptake of HIV testing and the prevalence of HIV infection among
hospitalized older adults in tertiary and secondary hospitals in Togo in 2018–2019. More than
a quarter of hospitalized older adults had never previously tested for HIV. Among participants
who accepted HIV testing, HIV prevalence was estimated at 7.1%, which was more than three
times that of the general population (2.3% in 2018) among people aged 15–49 years. Factors
associated with positive HIV status were living alone and being aged<60 years old.
Reaching the first 90–90% of people living with HIV know their status–remains a challenge
in SSA, especially for older adults. In rural Uganda, proportion of lifetime HIV testing among
older adults�50 years was 82% and recent (last 12 months) HIV testing was 53% [16], while
in rural area in Tanzania, lower HIV testing rate (ever tested) of 11.4% was reported in a cross-
sectional study which used baseline data of the Ifakara MZIMA cohort study in 2012/13 [18].
Experience of HIV testing in older adults may depend on where they tested (hospital or com-
munity setting) or whether they actively sought the testing or not [22]. In Botswana, among
the barriers to HIV testing, 76.8% older adults felt that they were not at risk of HIV infection
or did not have time to go to the testing center (6.5%) [29]. Also, older adults may mistake
HIV symptoms for those of normal ageing and not consider HIV as a potential cause [30].
Prior to this survey conducted in selected hospital settings, only two older adults in five
(43.7%) were offered and tested for HIV during their current hospitalization. Although sexual
transmission has been reported as the main route of transmission among older adults [6], they
Table 2. Factors associated with HIV prevalence among hospitalized older adults in Togo in 2018–2019.




HIV prevalence (%) N = 567 OR 95%CI p-value aOR 95%CI P-value aOR 95%CI p-value
Age (years)
� 60 4.2 1 1 1
50–59 11.0 3.12 [1.58–6.25] 0.001 3.33 [1.58–7.14] 0.002 3.12 [1.51–6.66] 0.002
Sex
Male 6.9 1 1 1
Female 7.2 1.07 [0.56–2.05] 0.832 0.65 [0.27–1.50] 0.318 0.72 [0.32–1.59] 0.418
Wards
Medicine 8.0 1 1 1
Surgery 3.7 0.39 [0.11–1.0] 0.079 0.37 [0.11–0.99] 0.074 0.38 [0.11–0.99] 0.075
Education level
No formal education 7.3 1 1 -
Primary school 6.4 0.84 [0.34–2.05] 0.710 0.66 [0.25–1.70] 0.391 - - -
Secondary/University 7.6 1.03 [0.49–2.24] 0.944 0.71 [0.30–1.73] 0.442 - - -
Marital status
Married/Living with a partner 5.9 1 1 1
Widowed 5.7 1.23 [0.54–2.65] 0.604 1.75 [0.66–4.52] 0.252 1.79 [0.68–4.60] 0.231
Living alone 22.2 6.23 [2.61–14.21] <0.001 5.92 [2.29–14.87] <0.001 5.83 [2.26–14.53] <0.001
95% CI: 95% confidence interval; OR: Odds Radio; aOR: adjusted Odds Ratio.
https://doi.org/10.1371/journal.pone.0246151.t002
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are often perceived as asexual patients by health care providers and are less likely to be offered
HIV testing [31, 32]. In Kenya, older adults expressed concerns with ageist discrimination spe-
cifically in hospital settings, characterized by providers’ reluctance or refusal to test [22].
Besides, health care providers may feel uncomfortable discussing sexual history, especially
with older adults [33]. HIV testing and prevention initiatives have historically focused on
younger population and key populations. PITC should also include older adults irrespective of
their marital status to detect undiagnosed cases at an early stage. Also, an alternative approach
with HIV self-testing could be proposed [34].
Some studies have reported data on HIV prevalence in Africa among older adults aged�50
years. Extrapolation from existing data from Demographic and Health Surveys (DHS) in SSA
yielded a prevalence of 4.0% among people aged>50 years [24]. Surveys that have included
older adults have reported HIV prevalence ranging from 5% among 50–64 years old in Kenya
to 13% among 50–54 years old in South Africa [35]. In Swaziland, prevalence was 6.4% among
adults aged 50 years or older, and 13% among men, and 7% among women aged 60–64 years
[35]. While comparing with HIV prevalence observed in the general population, another
review of data from 40 DHS conducted in 27 SSA countries between 2003 and 2012 found that
HIV prevalence among adults (45–59 years) was higher than in the general adult population,
except in Democratic Republic of Congo, Ethiopia, Mozambique, Sierra Leone, and Swaziland
[36]. In our study, one hospitalized older adult in 14 (7.1%) was infected with HIV and simi-
larly, a study conducted in a hospital in Dares-Salam in Tanzania reported high prevalence of
15% among those aged 55 years and older [37]. Thus, HIV prevalence among older adults var-
ies greatly across countries in SSA. However, comparisons should be made with caution since
the recruitment settings or strategies differ from one country to another. Nevertheless, these
results showed the need to focus prevention strategy on older adults.
Age and marital status were associated with HIV infection in the present study. Few studies
have reported data on HIV prevalence stratified by age among older adults in SSA. In South
Africa, a secondary data analysis based on the 2012 population-based nationally representative
multi-stage stratified cluster random household sample showed that increased risk of HIV was
significantly associated with age group 25–49 years and those 50 years and older compared
with young males 15–25 years [38]. In our study, the odds of being infected with HIV was
three times higher among older adults aged 50–59 years than in their counterparts aged 60
years and over. Globally, HIV prevalence appears to peak among people aged 45–60 years in
SSA. In Zimbabwe, HIV prevalence was high among men (23.4%) and women (21.3%) aged
45–54 years compared to those aged 15–44 years with 11.0% and 17.3%, respectively [14].
Based on available data in South Africa, the prevalence of HIV was 10.4% in males aged 50–54
years, 6.2% in males aged 55–59 years, and 3.5% in males aged�60 years [24]. Similar trends
were reported in Kenya, Rwanda, and in Uganda [24]. Intergenerational sex (having sex with
partners at least 10 years younger) without condom is a risky and frequent sexual behavior
among older adults [13, 39], which could explain this high prevalence. Also, this increased
prevalence may be related to practices such as wife inheritance, which are common in SSA and
where a widow marries a deceased’s relative [13].
Older adults who were living alone had six times the odds of being infected with HIV com-
pared to their counterparts who were married or living with a partner. Similarly in South
Africa, it was reported that married individuals who were living with their spouse had signifi-
cantly reduced odds of being HIV positive compared to all other marital status groups [40].
This could be explained by the fact that single individuals are more likely to have high numbers
of sexual partners and that older adults inconsistently use condom during sexual intercourse
[15, 41].
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This study has some limitations. First, we used the national algorithm for HIV diagnosis,
which does not allow to identify recent HIV infection [42]. Second, we recruited older adults
in clinical settings; therefore, HIV prevalence estimates could not be generalized to all older
adults in Togo and could be overestimated. However, this study documents missed opportuni-
ties of HIV testing among hospitalized older adults and the results showed the need to focus
prevention strategy in older adults. Also, it provided an overview of HIV prevalence in hospi-
tals in Togo and the need to test all older adults.
Conclusion and recommendations
This study explored HIV testing uptake, HIV prevalence and its associated factors among
older adults in hospitals in Togo. We observed high prevalence of HIV. Achieving the 90:90:90
targets requires identifying the largest possible number of HIV-positive individuals, including
older adults. In addition, management of HIV infection among older adults deserves great
attention as for non-communicable diseases. Thus, there is an urgent need to integrate older
adults into responses to the HIV epidemic and to strengthen targeted prevention care and
treatment in this population. Futures studies should better document virological responses in
older adults in Africa since immunological responses seems to be influenced by older age [43].
Moreover, the relationship between HIV infection and sexual practices among older adults
should be better documented especially in West Africa.
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